| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1524972A2 Compounds with antiparasitic activity and medicines containing same |
| 04/27/2005 | EP1150707B1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 04/27/2005 | EP0741569B1 Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610669A Heteroaryl-substituted aminocyclohexane derivatives |
| 04/27/2005 | CN1609206A Crystal structure of oxidosqualene cyclase |
| 04/27/2005 | CN1608618A Veterinary medicine injection containing chlorocyaniosaliamine or its sodium salt |
| 04/27/2005 | CN1198606C Benzoyl urea derivatrives injectable preparation and preparing method and their use |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884797 Targeted oxidative therapeutic formulation |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/21/2005 | WO2005012210A3 Antimicrobial active preparations containing terpene derivatives |
| 04/21/2005 | WO2004108940A3 Viral genome vectors |
| 04/21/2005 | US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 04/20/2005 | EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523317A2 Control of protozoa and protonzoan cysts that harbor legionella |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1175435B1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1607955A Methods and compositions for control of coccidiosis |
| 04/20/2005 | CN1197859C Febrifugine and isofebrifugine and processes for the preparation of both |
| 04/20/2005 | CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 04/20/2005 | CN1197583C Ivermectin slow-release injecta, and preparing process and use method thereof |
| 04/20/2005 | CN1197568C Dihydroarteannuin preparation for controlling broad-spectrum malaria and its preparation method |
| 04/19/2005 | US6881841 Dibenzosuberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 04/19/2005 | US6881726 Aqueous compositions containing metronidazole |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080045 topical administration; prevention of STDs preferably a viral disease other than HIV, e.g. HPV or genital herpes and especially acyclovir resistant genital herpes |
| 04/13/2005 | EP1522219A1 Antiparasitic formulations |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521779A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 04/13/2005 | EP1033982B1 Agents for combating neospora spec |
| 04/13/2005 | CN1606565A Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/13/2005 | CN1606446A Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606433A Methods for wet granulating azithromycin |
| 04/13/2005 | CN1606406A Mitocidal compositions and methods |
| 04/13/2005 | CN1196700C Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 04/13/2005 | CN1196485C Compositions for use against parasitic protozoa |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | CA2137961C Cyclic depsipeptides having 18 ring atoms, and their use for combating endoparasites |
| 04/07/2005 | WO2005030197A1 Compound artemisinin |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | US20050075511 Prevention of human and/or animal viral, bacterial, fungal or parasitic infections; plant fungicides, bactericides and/or herbicides; reduced side effects; environmentally friendly; such as ((n-formyl-n-hydroxyamino)-methoxy)-methyl phosphonic acid disodium salt |
| 04/07/2005 | US20050075496 Plasmodium falciparum antigens and their vaccine and diagnostic applications |
| 04/07/2005 | US20050072372 Hair removal and animal husbandry method |
| 04/06/2005 | EP1520015A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519724A1 Fredericamycin derivatives as medicaments for treating tumours |
| 04/06/2005 | EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1602858A Arteannuin preparation for treating gynecopathy |
| 04/06/2005 | CN1195758C Optical pure analog of camptothecine |
| 04/06/2005 | CN1195757C Optically pure camptothecin analogues |
| 04/05/2005 | US6875779 Cyclooxygenase inhibitor |
| 04/05/2005 | US6875746 Anticancer anthraquinones and method of use thereof |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 04/05/2005 | US6875612 Expression vector coding proteins for use in the treatment of tumors |
| 03/31/2005 | WO2005027934A1 Prolyl oligopeptidase inhibitor |
| 03/31/2005 | WO2005027893A1 HUMAN β-DEFENSIN SECRETION PROMOTER |
| 03/31/2005 | US20050070595 Complex of trioxane with iron compound |
| 03/31/2005 | US20050070491 Immunostimulatory nucleic acid molecules |
| 03/31/2005 | US20050070463 membrane proteins associated with LPSs (lipopolysaccharides), for inducing maturation of dendritic cells; membrane fraction has a proteoglycan titer, represented by the sum of the contents of galactose and of proteins, between 1.2 g/l - 3.4 g/l for galactose and between 7.5 g/l - 14.9 g/l for proteins |
| 03/31/2005 | US20050069878 Proteins associated with cell growth, differentiation, and death |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | DE10341342A1 Herbal active agent combinations of agnus castus and barberry, useful, especially in feed additive form, for combating Simulium mosquito infestation in animals, e.g. summer eczema in horses |
| 03/31/2005 | CA2676567A1 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors |
| 03/31/2005 | CA2538760A1 Human .beta.-defensin secretion promoter |
| 03/30/2005 | EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 03/30/2005 | EP1517885A2 Aminoacetonitrile derivatives suitable for controlling parasites |
| 03/30/2005 | EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 03/30/2005 | EP1517879A1 Aminoalkylphenols, methods of using and making the same |
| 03/30/2005 | EP1517700A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 03/30/2005 | CN1602296A Amidoacetonitrile derivatives |
| 03/30/2005 | CN1602292A Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 03/30/2005 | CN1194758C Vaginal lactobacillus medicant |
| 03/29/2005 | US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/29/2005 | US6872713 Plant extracts |
| 03/24/2005 | WO2005000348A3 Vaccines inducing nkt-cell and toll-like-receptor activation |
| 03/24/2005 | WO2004103985A3 Derivatives of fusarochromanone as therapeutic agents |
| 03/24/2005 | WO2004084645A3 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050064534 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 03/24/2005 | US20050064032 Dosage form, device, and methods of treatment |
| 03/24/2005 | US20050064027 Prolonged gastric retention time due to bioadhesion (which may be polymers, metal oxides, or ligands for specific mucosal components); macrospheres for delivery of acyclovir for example |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | US20050063907 Radioopaque sustained release pharmaceutical system |
| 03/23/2005 | EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 03/23/2005 | EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 03/23/2005 | CN1599741A Thioether substituted imidazoquinolines |
| 03/23/2005 | CN1599740A Amide substituted imidazopyridines |
| 03/23/2005 | CN1599739A Sulfonamido substituted imidazopyridines |